What is the current Nuclear Medicine Therapeutics Market size?

The Nuclear Medicine Therapeutics Market is projected to register a CAGR of 15.16% during the forecast period (2024-2029) Read More

Who are the key players in Nuclear Medicine Therapeutics Market?

IBA Radiopharma Solutions, Bayer AG, Alpha Tau Medical Ltd, Actinium Pharmaceutical Inc. and Jubilant Life Sciences Company are the major companies operating in the Nuclear Medicine Therapeutics Market. Read More

Which is the fastest growing region in Nuclear Medicine Therapeutics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Nuclear Medicine Therapeutics Market?

In 2024, the North America accounts for the largest market share in Nuclear Medicine Therapeutics Market. Read More

What years does this Nuclear Medicine Therapeutics Market cover?

The report covers the Nuclear Medicine Therapeutics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Nuclear Medicine Therapeutics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Nuclear Medicine Therapeutics Market Share

Statistics for the 2023 & 2024 Nuclear Medicine Therapeutics market share, created by Mordor Intelligence™ Industry Reports. Nuclear Medicine Therapeutics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Nuclear Medicine Therapeutics Industry

The nuclear medicine therapeutics market is consolidated and primarily dominated by a few key players operating globally and regionally. These companies are well-known and hold significant market shares. The competitive landscape of the market includes an analysis of international and local companies.

Some of the major players in the nuclear medicine therapeutics market include Actinium Pharmaceutical Inc., Alpha Tau Medical Ltd, Bayer AG, Fusion Pharmaceuticals, IBA Radiopharma Solutions, RadioMedix Inc., Telix Pharmaceuticals Ltd, NTP Radioisotopes, Bracco SpA, Cardinal Health Inc., Nordion Inc. (Sotera Health Company), and Triad Isotopes (Jubilant Life Sciences).